US Stock MarketDetailed Quotes

CARM Carisma Therapeutics

Watchlist
  • 0.478
  • -0.079-14.17%
Trading Dec 12 15:57 ET
19.94MMarket Cap-0.31P/E (TTM)

Carisma Therapeutics Key Stats

Earnings

Revenue Breakdown

Financial Indicators

Income Statement

Balance Sheet

Cash Flow

Carisma Therapeutics Earnings Estimates

Revenue

EPS

EBIT

Revenue is based on 2 analyst forecasts. Estimate data is from S&P, and actual data is from Income Statement

Currency: USD

Actual
Estimate
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 4.693M--
--2024/Q4-- / 5.421M--
--2024/Q33.385M / 5.049M--
--2024/Q29.197M / 3.924M--
--2024/Q13.397M / 4.396M--
DatePeriodRevenue/EstimateEarnings Call
--2025/Q1-- / 4.693M--
--2024/Q4-- / 5.421M--
--2024/Q33.385M / 5.049M--
--2024/Q29.197M / 3.924M--
--2024/Q13.397M / 4.396M--

Unlock Free Earnings Estimates

Carisma Therapeutics Earnings Reports

  • Carisma Therapeutics | 10-Q: Q3 2024 Earnings Report

    Nov 7 07:43 ET

  • Carisma Therapeutics | 8-K: Carisma Therapeutics Reports Third Quarter 2024 Financial Results and Recent Business Highlights

    Nov 7 07:38 ET

  • Carisma Therapeutics | 10-Q: Q2 2024 Earnings Report

    Aug 8 07:44 ET

  • Carisma Therapeutics | 8-K: Carisma Therapeutics Reports Second Quarter 2024 Financial Results and Recent Business Highlights

    Aug 8 07:39 ET

    • Read more

    Analysis

    Analyst Rating

    Updated: Dec 12, 2024

    Buy

    • Buy

      25.00%

    • Hold

      75.00%

    • Sell

      0.00%

    Price Target

    No Data

    Heat List
    US
    Overall
    Symbol
    Price
    % Chg

    No Data